scholarly journals Relationship between blood pressure and blood levels of angiotensin I converting enzyme inhibitor (SQ 14,225).

1981 ◽  
Vol 45 (9) ◽  
pp. 1025-1029
Author(s):  
MASANOBU HONDA ◽  
YOICHI IZUMI ◽  
YUKINORI KAWAHARA ◽  
MICHINOBU HATANO
Keyword(s):  
Blood Pressure ◽  
Enzyme Inhibitor ◽  
Blood Levels ◽  
Converting Enzyme ◽  
Angiotensin I ◽  
Converting Enzyme Inhibitor ◽  
Angiotensin I Converting Enzyme

Effects of angiotensin I converting enzyme inhibitor (SQ 14225) on control of aldosterone

1980 ◽  
Vol 94 (2) ◽  
pp. 213-220 ◽  
Author(s):  
Toyohisa Eguchi ◽  
Ikuo Saito ◽  
Ryuichi Nakamura ◽  
Toshiyuki Yasui ◽  
Takao Saruta
Keyword(s):  
Blood Pressure ◽  
Enzyme Inhibitor ◽  
Plasma Renin ◽  
Inhibitory Effect ◽  
Converting Enzyme ◽  
Angiotensin I ◽  
Converting Enzyme Inhibitor ◽  
Angiotensin I Converting Enzyme ◽  
Pre Treatment ◽  
Remarkable Reduction

Abstract. To study effects of angiotensin I converting enzyme inhibitor (CEI), SQ 14225, on plasma aldosterone (PA), angiotensin I (AI), angiotensin II (AII), potassium and ACTH were administered with or without the simultaneous injection of SQ 14225 in rabbits. The direct effect of bradykinin on PA was also examined, since it is suspected to augment the action of kinin under the administration of CEI. In rabbits the dose of 1 mg/kg of SQ 14225 by a bolus injection resulted in a marked elevation of plasma renin activity (PRA) and moderate but significant decreases in circulating AII and PA with only a little change of blood pressure. Decrements in circulating AII and those in PA observed after the injection of SQ 14225 were well correlated (r = 0.585, P < 0.05). Stimulatory effects of AII, potassium and ACTH on PA were not affected by SQ 14225, however, those of AI on PA and blood pressure were completely inhibited by pre-treatment of SQ 14225. The infusion of bradykinin showed a remarkable reduction in blood pressure and a small increment in PRA, circulating AII and PA. These results may suggest that the inhibitory effect of acutely administered SQ 14225 on PA is mainly due to the inhibition of conversion from AI to AII, but not direct effects on adrenal glands. Furthermore, it was suggested that the augmented kinin is not related to the inhibitory effect of SQ 14225 on PA. In addition, the administration of SQ 14225 does not change the effects of potassium and ACTH on PA.

Sign in / Sign up

Export Citation Format

Share Document